| Literature DB >> 29374001 |
Beatriz Martines Souza1, Daiana Moreli Soares Santos1, Aline Silva Braga1, Natália Mello Dos Santos2, Daniela Rios2, Marilia Afonso Rabelo Buzalaf1, Ana Carolina Magalhães1.
Abstract
BACKGROUND: Titanium tetrafluoride (TiF4) has regained interest due to new formulations that have been shown to be more effective against tooth demineralization than sodium fluoride (NaF) formulations in vitro and in situ.Entities:
Keywords: clinical trial; dental caries; topical fluorides
Year: 2018 PMID: 29374001 PMCID: PMC5807625 DOI: 10.2196/resprot.9376
Source DB: PubMed Journal: JMIR Res Protoc ISSN: 1929-0748
Distribution of selected schools according to the regions of Bauru city (São Paulo, Brazil).
| Region | Name of school |
| North | EMEFa José Romão |
| EMEF Geraldo Arone | |
| South | EMEF Santa Maria |
| East | EMEF Thereza Tarzia - Irmã Rosamaria Tarzia |
| West | EMEF Ivan Engler de Almeida |
aEMEF: municipal school of fundamental education.
Figure 1Flowchart of the study.
Figure 2The Wong-Baker Visual Scale (WBPS), where 0 is very good (no pain/discomfort) and 10 is highly dissatisfied (worst possible pain/discomfort).
Modified Nyvad’s scores [12].
| Score | Description |
| Score 0 | Sound enamel |
| Score 1 | Active white spot lesion – not cavitated |
| Score 2 | Inactive white spot lesion – not cavitated |
| Score 3 | Cavitated enamel (tooth with cavity, restored, or extracted) |
International Caries Detection and Assessment System (ICDAS) scores [15].
| Score | Classification criteria |
| 0 | No or subtle change in enamel translucency after prolonged drying (5s) in area of biofilm accumulation |
| 1 | Visible white spot after drying (no loss of surface continuity) or pigmentation restricted to confines of a pit or fissure |
| 2 | White spot visible on wet surface (no loss of surface continuity) or pigmentation that extrapolates confines of a pit or fissure |
| 3 | Localized cavitation (or loss of continuity) in opaque or pigmented enamel |
| 4 | Underlying dark shadow from dentin, with or without cavitation of enamel |
| 5 | Cavitated enamel with exposure of the underlying dentin, involving up to half of the analyzed surface |
| 6 | Cavitated enamel with exposure of the underlying dentin, involving more than half of the analyzed surface |
Nyvad’s scores [12] at the baseline and after 1 month of treatment (final) for TiF4, NaF and placebo treatments.
| Measures | TiF4 | NaF | Placebo | |||||
| Baseline | Final | Baseline | Final | Baseline | Final | |||
| Nyvad index, mean±SD | 1.0±0.00 | 1.0±0.00 | 0.97±0.15 | 1.03±0.15a | 0.99±0.06 | 1.08±0.24b | ||
| Dfc, median (min-max) | 0.0 (0.0 to 0.0) | 0.0 (–0.7 to 0.0) | 0.0 (–1.0 to 0.0) | |||||
aOne patient presented two teeth that progressed from score 0 to 1 and 1 patient had one lesion that progressed from score 1 to 3.
bOne patient presented one tooth that progressed from score 0 to 3 and one patient had one lesion that progressed from score 1 to 3.
cDf: degrees of freedom. Df = baseline – final value, where positive values indicate regression and negative values indicate lesions progression. Kruskal-Wallis Test (p=.39).
Median (minimum-maximum values) obtained in quantitative light-induced fluorescence (QLF) analysis at the first month compared to the baseline.
| Type of varnish | ΔWS area (mm2)a,b | ΔΔF (%)b,c |
| TiF4 | 0.01 (–9.15 to 1.19) | –1.29 (–16.30 to 4.74) |
| NaF | 0.17 (–2.38 to 1.47) | –0.55 (–5.80 to 6.10) |
| Placebo | 0.19 (–1.14 to 4.36) | –0.23 (–5.17 to 5.10) |
aΔWS: variation of the white spot lesion area. For ΔWS, negative values mean progression (demineralization), and positive values, regression (remineralization). The opposite is valid for ΔΔF.
bKruskal-Wallis Test (p=.59 and p=.45, respectively).
cΔΔF: variation of the mean fluorescence loss.
Mean percentage (%) of the degree of patient satisfaction after the first 4 applications of the TiF4, NaF and placebo varnishes using the Wong-Baker Pain Scale.
| Wong-Baker Pain Scale | Type of varnish, mean±SD (%) | ||
| TiF4 | NaF | Placebo | |
| 0 | 75±8 | 86±6 | 76±11 |
| 2 | 20±5 | 12±6 | 17±9 |
| 4 | 5±4 | 2±3 | 3±3 |
| 6 | 0±0 | 0±0 | 3±3 |
| 8 | 0±0 | 0±0 | 0±0 |
| 10 | 0±0 | 0±0 | 1±3 |
Number of patients included in the analysis of satisfaction (Wong-Baker Pain scale) after the first four varnish applications.
| Wong-Baker Pain Scale | Number of patients by varnish type | |||||||||||
| TiF4 | NaF | Placebo | ||||||||||
| 1sta | 2nd | 3rd | 4th | 1st | 2nd | 3rd | 4th | 1st | 2nd | 3rd | 4th | |
| 0 | 18 | 15 | 16 | 14 | 19 | 17 | 19 | 17 | 18 | 16 | 13 | 14 |
| 2 | 3 | 5 | 4 | 5 | 1 | 3 | 2 | 4 | 1 | 4 | 5 | 4 |
| 4 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 20 | 20 | 20 |
aThe first (1st), the second (2nd), the third (3rd) and the fourth (4th) varnish application.